Edward J Cain
Examiner (ID: 9172, Phone: (571)272-1118 , Office: P/1762 )
Most Active Art Unit | 1714 |
Art Unit(s) | 1714, 1796, 1762, 1509, 0, 1511 |
Total Applications | 3560 |
Issued Applications | 2947 |
Pending Applications | 151 |
Abandoned Applications | 462 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9421338
[patent_doc_number] => 20140105989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'Treatment Methods with Low-Dose, Longer-Acting Formulations of Local Anesthetics and Other Agents'
[patent_app_type] => utility
[patent_app_number] => 14/138279
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15430
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138279
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138279 | Treatment Methods with Low-Dose, Longer-Acting Formulations of Local Anesthetics and Other Agents | Dec 22, 2013 | Abandoned |
Array
(
[id] => 9491762
[patent_doc_number] => 20140142167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer'
[patent_app_type] => utility
[patent_app_number] => 14/108875
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6263
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14108875
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/108875 | Micellar Preparation Containing Sparingly Water-Soluble Anticancer Agent And Novel Block Copolymer | Dec 16, 2013 | Abandoned |
Array
(
[id] => 11113454
[patent_doc_number] => 20160310426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES'
[patent_app_type] => utility
[patent_app_number] => 14/916439
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14835
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916439 | Microparticles and nanoparticles having negative surface charges | Dec 3, 2013 | Issued |
Array
(
[id] => 10443220
[patent_doc_number] => 20150328232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/648632
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 23359
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648632 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME | Dec 1, 2013 | Abandoned |
Array
(
[id] => 9306087
[patent_doc_number] => 20140044761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'HYBRID FRAGRANCE ENCAPSULATE FORMULATION AND METHOD FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/057127
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11900
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057127
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057127 | Hybrid fragrance encapsulate formulation and method for using the same | Oct 17, 2013 | Issued |
Array
(
[id] => 13915639
[patent_doc_number] => 10201916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof
[patent_app_type] => utility
[patent_app_number] => 14/056134
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 32633
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056134
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/056134 | Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof | Oct 16, 2013 | Issued |
Array
(
[id] => 9634360
[patent_doc_number] => 20140212468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'PREPARATION METHOD OF AN IMPLANT COMPRISING DRUG DELIVERY LAYER AND IMPLANT COMPOSITION FOR LIVING DONOR TRANSPLANTATION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/045109
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 8100
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045109 | PREPARATION METHOD OF AN IMPLANT COMPRISING DRUG DELIVERY LAYER AND IMPLANT COMPOSITION FOR LIVING DONOR TRANSPLANTATION COMPRISING THE SAME | Oct 2, 2013 | Abandoned |
Array
(
[id] => 9560762
[patent_doc_number] => 20140178475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same'
[patent_app_type] => utility
[patent_app_number] => 14/027689
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27769
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/027689 | Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same | Sep 15, 2013 | Abandoned |
Array
(
[id] => 10331779
[patent_doc_number] => 20150216783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'OXIDISED CELLULOSE'
[patent_app_type] => utility
[patent_app_number] => 14/422478
[patent_app_country] => US
[patent_app_date] => 2013-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11147
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422478
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422478 | OXIDISED CELLULOSE | Aug 7, 2013 | Abandoned |
Array
(
[id] => 9161032
[patent_doc_number] => 20130309310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Injectable Nanoparticulate Olanzapine Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/950235
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11938
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/950235 | Injectable Nanoparticulate Olanzapine Formulations | Jul 23, 2013 | Abandoned |
Array
(
[id] => 9054103
[patent_doc_number] => 20130251817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'CANCER CELL TARGETING USING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/891341
[patent_app_country] => US
[patent_app_date] => 2013-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30716
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13891341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/891341 | Cancer cell targeting using nanoparticles | May 9, 2013 | Issued |
Array
(
[id] => 9054052
[patent_doc_number] => 20130251766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'CANCER CELL TARGETING USING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/891362
[patent_app_country] => US
[patent_app_date] => 2013-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30713
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13891362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/891362 | Cancer cell targeting using nanoparticles | May 9, 2013 | Issued |
Array
(
[id] => 9054102
[patent_doc_number] => 20130251816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'CANCER CELL TARGETING USING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/891334
[patent_app_country] => US
[patent_app_date] => 2013-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30717
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13891334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/891334 | Cancer cell targeting using nanoparticles | May 9, 2013 | Issued |
Array
(
[id] => 9055340
[patent_doc_number] => 20130253055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'POWDEROUS FORMULATIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/887608
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1615
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887608 | POWDEROUS FORMULATIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS | May 5, 2013 | Abandoned |
Array
(
[id] => 9041069
[patent_doc_number] => 20130243707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'TOPICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/852615
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33460
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852615
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852615 | TOPICAL COMPOSITIONS | Mar 27, 2013 | Abandoned |
Array
(
[id] => 9736182
[patent_doc_number] => 20140271894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'MATRIX-INCORPORATED FLUORESCENT POROUS SILICA PARTICLES FOR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/803604
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803604
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803604 | MATRIX-INCORPORATED FLUORESCENT POROUS SILICA PARTICLES FOR DRUG DELIVERY | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9094974
[patent_doc_number] => 20130274285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/826186
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 108336
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826186
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826186 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Mar 13, 2013 | Issued |
Array
(
[id] => 9422423
[patent_doc_number] => 20140107074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/804752
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 108147
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13804752
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/804752 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Mar 13, 2013 | Issued |
Array
(
[id] => 11611419
[patent_doc_number] => 09649261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Method of applying makeup to a surface and a kit for implementing such a method'
[patent_app_type] => utility
[patent_app_number] => 13/777573
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 20
[patent_no_of_words] => 45262
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13777573
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/777573 | Method of applying makeup to a surface and a kit for implementing such a method | Feb 25, 2013 | Issued |
Array
(
[id] => 8821012
[patent_doc_number] => 20130122057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'Organophosphorous, Multivalent Metal Compounds, and Bioactive Glass Material Macromolecular Network Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 13/673490
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10569
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673490 | Organophosphorous, Multivalent Metal Compounds, and Bioactive Glass Material Macromolecular Network Compositions and Methods | Nov 8, 2012 | Abandoned |